AI could transform how scientists assess drug safety and toxicity
A new vision for AI to streamline the complex safety testing of new drugs.
Deep Dive
A new white paper explores how 'agentic' AI systems could revolutionize toxicologic pathology, the science of assessing drug safety. These AI agents would coordinate fragmented data from images, lab results, and literature to assist pathologists in generating reports. The paper, based on expert discussions, outlines a phased adoption roadmap and identifies key barriers like the need for validation and transparency to ensure safe integration into nonclinical studies.
Why It Matters
This could speed up drug development and improve safety assessments, potentially getting life-saving treatments to patients faster.